Submitted by Anonymous (not verified) on 25 September 2023 - 12:44
Human medicines European public assessment report (EPAR): Amglidia, glibenclamide, Diabetes Mellitus, Date of authorisation: 24/05/2018, Revision: 7, Status: Authorised
Source: